Researchers constructed various genetically engineered mouse models of multiple myeloma and found that the MAPK-MYC pathway plays a critical role in disease progression (54).The activation of MYC correlates with tumor progression rate and affects immune cell infiltration and function within the tumor microenvironment. This evidence concerns the gene MYC and plasma cell myeloma.